C4orf50
gene geneOn this page
Also known as FLJ46481
Summary
C4orf50 (chromosome 4 open reading frame 50, HGNC:33766) is a protein-coding gene on chromosome 4p16.2-p16.1, encoding Uncharacterized protein C4orf50 (Q6ZRC1).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 12 total — 2 pathogenic
- MANE Select transcript:
NM_001364689
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33766 |
| Approved symbol | C4orf50 |
| Name | chromosome 4 open reading frame 50 |
| Location | 4p16.2-p16.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ46481 |
| Ensembl gene | ENSG00000181215 |
| Ensembl biotype | protein_coding |
| Entrez | 389197 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
ENST00000531445, ENST00000639345, ENST00000711657
RefSeq mRNA: 2 — MANE Select: NM_001364689
NM_001364689, NM_001364690
CCDS: CCDS93473
Canonical transcript exons
ENST00000711657 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001364444 | 5975899 | 5975955 |
| ENSE00001374945 | 5973659 | 5973841 |
| ENSE00001375947 | 5980174 | 5980338 |
| ENSE00001379628 | 5967414 | 5967462 |
| ENSE00001390561 | 5965024 | 5965145 |
| ENSE00002190921 | 5988347 | 5990824 |
| ENSE00003792539 | 6011830 | 6011968 |
| ENSE00003792726 | 5992803 | 5992930 |
| ENSE00003795534 | 6007996 | 6008532 |
| ENSE00003799198 | 5994347 | 5994476 |
| ENSE00004016324 | 5959375 | 5959626 |
| ENSE00004016325 | 6018145 | 6018431 |
Expression profiles
Bgee: expression breadth broad, 49 present calls, max score 78.83.
FANTOM5 (CAGE): breadth broad, TPM avg 4.0134 / max 158.6347, expressed in 375 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 51233 | 4.0134 | 375 |
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| nucleus accumbens | UBERON:0001882 | 78.83 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 77.07 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.34 | silver quality |
| putamen | UBERON:0001874 | 74.34 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.16 | gold quality |
| caudate nucleus | UBERON:0001873 | 73.87 | gold quality |
| frontal cortex | UBERON:0001870 | 73.02 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 71.45 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 71.32 | gold quality |
| cerebral cortex | UBERON:0000956 | 71.22 | gold quality |
| right frontal lobe | UBERON:0002810 | 70.80 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 70.57 | gold quality |
| primary visual cortex | UBERON:0002436 | 70.23 | gold quality |
| cortical plate | UBERON:0005343 | 69.14 | gold quality |
| Ammon’s horn | UBERON:0001954 | 68.11 | gold quality |
| temporal lobe | UBERON:0001871 | 67.67 | gold quality |
| amygdala | UBERON:0001876 | 67.51 | gold quality |
| hypothalamus | UBERON:0001898 | 66.90 | gold quality |
| brain | UBERON:0000955 | 65.19 | gold quality |
| substantia nigra | UBERON:0002038 | 58.95 | gold quality |
| granulocyte | CL:0000094 | 58.46 | gold quality |
| corpus callosum | UBERON:0002336 | 57.32 | gold quality |
| colonic epithelium | UBERON:0000397 | 57.10 | gold quality |
| bone marrow cell | CL:0002092 | 54.02 | gold quality |
| ventricular zone | UBERON:0003053 | 53.23 | gold quality |
| islet of Langerhans | UBERON:0000006 | 49.92 | gold quality |
| bone marrow | UBERON:0002371 | 48.54 | gold quality |
| pituitary gland | UBERON:0000007 | 46.82 | gold quality |
| sural nerve | UBERON:0015488 | 45.17 | gold quality |
| lymph node | UBERON:0000029 | 44.84 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.86 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gm1043 | ENSMUSG00000117286 |
| rattus_norvegicus | C14h4orf50 | ENSRNOG00000038427 |
Protein
Protein identifiers
Uncharacterized protein C4orf50 — Q6ZRC1 (reviewed: Q6ZRC1)
All UniProt accessions (2): A0A1W2PRI9, Q6ZRC1
UniProt curated annotations — full annotation on UniProt →
RefSeq proteins (2): NP_001351618, NP_001351619 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032771 | DUF4527 | Family |
Pfam: PF15030
UniProt features (19 total): region of interest 7, compositionally biased region 4, sequence variant 4, coiled-coil region 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZRC1-F1 | 55.65 | 0.26 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 9 (showing top):
chr4p16, MARTENS_TRETINOIN_RESPONSE_UP, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GATA1_05, ZNF10_TARGET_GENES, DESCARTES_MAIN_FETAL_THYMIC_EPITHELIAL_CELLS, DESCARTES_FETAL_EYE_GANGLION_CELLS, DESCARTES_FETAL_INTESTINE_ENS_NEURONS, ZNF134_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
52 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C4orf50 | H6PD | O95479 | 205 |
| C4orf50 | CLCF1 | Q9UBD9 | 180 |
| C4orf50 | OTOP1 | Q7RTM1 | 156 |
| C4orf50 | RAB30 | Q15771 | 155 |
| C4orf50 | NNT | Q13423 | 128 |
| C4orf50 | K7N7A8 | K7N7A8 | 128 |
| C4orf50 | SERINC4 | A6NH21 | 48 |
| C4orf50 | TACC2 | O95359 | 48 |
| C4orf50 | LY9 | Q9HBG7 | 0 |
| C4orf50 | LRRC53 | A6NM62 | 0 |
| C4orf50 | PRDM9 | Q9NQV7 | 0 |
| C4orf50 | TNFRSF10D | Q9UBN6 | 0 |
| C4orf50 | ADGRE1 | Q14246 | 0 |
| C4orf50 | OR2AJ1 | Q8NGZ0 | 0 |
| C4orf50 | KLRG2 | A4D1S0 | 0 |
| C4orf50 | MARCHF5 | Q9NX47 | 0 |
| C4orf50 | OR51I1 | Q9H343 | 0 |
| C4orf50 | NHSL3 | Q9P206 | 0 |
| C4orf50 | FASTKD2 | Q9NYY8 | 0 |
| C4orf50 | CD44 | P16070 | 0 |
| C4orf50 | SAMD1 | Q6SPF0 | 0 |
| C4orf50 | PERCC1 | A0A1W2PR82 | 0 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NDEL1 | C4orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
ESM2 similar proteins: A0A096LP49, A0A1B0GVZ6, A2VE02, A5D7I0, A6NDZ8, A6NE82, A6NGG8, A6NJ08, A6NJI1, A6QP24, A7YY35, A8MYA2, O94850, P50617, Q0P5M0, Q2KIL8, Q2KIS6, Q3SY00, Q3ZBU3, Q497N6, Q4R736, Q5BMD4, Q5JTZ5, Q5M844, Q5VZ46, Q5XIK6, Q66MI6, Q6AXP4, Q6PAC4, Q6ZRC1, Q7L2K0, Q7Z591, Q80TS7, Q80VW7, Q8BFY7, Q8BHW6, Q8IXW0, Q8IYS4, Q8IYX3, Q8N4L8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
12 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2424447 | NC_000004.11:g.(?4861627)(6304195_?)del | Pathogenic |
| 816497 | GRCh37/hg19 4p16.3-15.2(chr4:49450-24280482)x1 | Pathogenic |
SpliceAI
3968 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:5973658:CCT:C | donor_gain | 1.0000 |
| 4:5973669:C:CA | donor_gain | 1.0000 |
| 4:5973698:AG:A | donor_gain | 1.0000 |
| 4:5973698:AGC:A | donor_gain | 1.0000 |
| 4:5973699:G:C | donor_gain | 1.0000 |
| 4:5980166:T:TA | donor_gain | 1.0000 |
| 4:5980167:C:A | donor_gain | 1.0000 |
| 4:5980190:T:TA | donor_gain | 1.0000 |
| 4:6060419:CTCA:C | donor_loss | 1.0000 |
| 4:6060420:TCAC:T | donor_loss | 1.0000 |
| 4:6060421:CACC:C | donor_loss | 1.0000 |
| 4:6060423:C:T | donor_loss | 1.0000 |
| 4:6060503:CGAGT:C | acceptor_gain | 1.0000 |
| 4:6060504:GAGT:G | acceptor_gain | 1.0000 |
| 4:6060506:GT:G | acceptor_gain | 1.0000 |
| 4:6060506:GTC:G | acceptor_loss | 1.0000 |
| 4:6060507:TCTGG:T | acceptor_loss | 1.0000 |
| 4:6060508:C:CC | acceptor_gain | 1.0000 |
| 4:6060508:C:T | acceptor_loss | 1.0000 |
| 4:6062310:AC:A | donor_gain | 1.0000 |
| 4:6062311:CC:C | donor_gain | 1.0000 |
| 4:6062439:GC:G | acceptor_gain | 1.0000 |
| 4:6062440:CC:C | acceptor_gain | 1.0000 |
| 4:6062441:C:CC | acceptor_gain | 1.0000 |
| 4:6062444:CACA:C | acceptor_gain | 1.0000 |
| 4:6062446:C:CT | acceptor_gain | 1.0000 |
| 4:6062447:A:AC | acceptor_gain | 1.0000 |
| 4:6062447:A:C | acceptor_gain | 1.0000 |
| 4:6062450:A:AC | acceptor_gain | 1.0000 |
| 4:6062450:A:C | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000000289 (4:5918678 C>T), RS1000010262 (4:5951775 G>A,C), RS10000138 (4:5949970 C>A,T), RS1000028695 (4:6016751 A>C), RS1000071891 (4:5954375 C>T), RS1000110236 (4:5996761 G>C), RS1000140446 (4:5917706 T>A), RS1000188189 (4:5978435 G>C), RS1000191624 (4:6018636 T>C), RS1000197477 (4:5946471 C>G), RS10002154 (4:5931726 C>T), RS1000219210 (4:5978788 C>T), RS1000241567 (4:6012010 T>G), RS1000244751 (4:5945743 A>G), RS1000247628 (4:5951044 A>G)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:189500
GenCC curated gene-disease
Mondo (1): tooth and nail syndrome (MONDO:0008582)
Orphanet (1): Hypodontia-dysplasia of nails syndrome (Orphanet:2228)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002040_6 | Blood trace element (Zn levels) | 3.000000e-06 |
| GCST012051_4 | Systolic blood pressure | 8.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C536736 | Witkop syndrome (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): tooth and nail syndrome